10 Moderna operations leaders

Drug substance and drug product operations sit side by side in this group of Moderna operations leaders, with five site head titles across the Norwood, INT and MITC sites plus the company's chief technical operations and quality officer. It fits a biotech team planning how to stand up a new mRNA or biologics site, staff manufacturing as programs move from clinical to commercial supply, or connect quality with plant operations.

10 professionals1 companyData retrieved September 28, 2026

Professionals to explore

  1. Amanda Ashcraft

    LinkedIn

    Experience: Site Head, VP Norwood Drug Substance Operations · Moderna

    Site Head, VP Norwood Drug Substance Operations at Moderna since November 2025. In 2025 Amanda Ashcraft also served as Head of Global Drug Substance Process and Laboratory Strategy, Ad-Interim Site Head Norwood Drug Substance Operations and Ad-Interim Head of Global Quality Management System (QMS), and was Executive Director, Head of Quality (2023–2025). The quality background suits questions on running a drug substance site with quality built in.

    Is this you? Claim your profile and get paid for calls.

  2. Deborah Soto-Ortega

    LinkedIn

    Experience: Executive Director - Site Head · Moderna

    As Head of Operations at Moderna's Marlborough INT facility, Deborah Soto-Ortega led its operational startup from construction onward and has been Executive Director - Site Head since November 2025. Former Sr. Director, INT Commercial Ops Readiness Lead (2023–2025) and Sr. Director, Engineering Projects - Clinical Manufacturing (2022–2023) at Moderna, plus Director roles at Amgen. The fit for site startup and commercial readiness questions.

    Is this you? Claim your profile and get paid for calls.

  3. Elizabeth Sullivan

    LinkedIn

    Experience: INT Site Head, Executive Director of Operations · Moderna

    Elizabeth Sullivan has been INT Site Head, Executive Director of Operations at Moderna since January 2023. At Adverum Biotechnologies the roles were Vice President, Tech Ops Executive Director, Tech Development (2021–2022) and Executive Director, Manufacturing and Operations, Site Head (2021), and the summary describes building and scaling operations across mRNA, gene therapy and monoclonal antibodies from IND to approval. Ask about CMC strategy and site leadership.

    Is this you? Claim your profile and get paid for calls.

  4. Jake Haworth

    LinkedIn

    Experience: Senior Director of Operations · Moderna

    Senior Director of Operations at Moderna since October 2025, Jake Haworth was Director (2023–2025) and Associate Director (2022–2023), Research and Early Development Operations, at Moderna. Also Secretary, Board of Directors at LabOps Unite Community since 2023. Research lab operations, rather than manufacturing, are the topic here.

    Is this you? Claim your profile and get paid for calls.

  5. Jeff Savard

    LinkedIn

    Experience: Head, INT Manufacturing · Moderna

    Former VP, Norwood Drug Substance Site Head at Moderna (2024–2025) and Head, INT Manufacturing there since November 2025; Executive Director, DS Operations at Moderna (2022–2024). Jeff Savard, a chemical engineer, writes of process equipment design, technical transfer, validation and commercial support of biologics drug substance manufacturing, and held Single Use Facility Manufacturing director roles at Bristol Myers Squibb. Ask about tech transfer into a drug substance plant.

    Is this you? Claim your profile and get paid for calls.

  6. Jerh Collins

    LinkedIn

    Experience: Chief Technical Operations and Quality Officer · Moderna

    Chief Technical Operations and Quality Officer at Moderna since October 2022 and a member of its Executive Committee. Jerh Collins was Chief Culture Officer (2020–2022) and Head of Global Chemical Operations and Anti-Infectives (2017–2019) at Novartis. That combination fits questions on how technical operations and quality report together at the top of a biotech.

    Is this you? Claim your profile and get paid for calls.

  7. Michelle Rodriguez

    LinkedIn

    Experience: VP, Drug Product Operations · Moderna

    VP, Drug Product Operations at Moderna since June 2023, Michelle Rodriguez came from quality leadership: Vice President Global Quality for Biologic & Sterile Ops at Bristol Myers Squibb (2020–2023), Head of Quality, Latin America & Puerto Rico at Teva Pharmaceuticals (2018–2020) and Executive Director Quality at Novartis (2012–2018). Strong on sterile drug product operations seen from the quality side.

    Is this you? Claim your profile and get paid for calls.

  8. Nicolas Chornet

    LinkedIn

    Experience: Senior Vice President Manufacturing and Site Head MITC · Moderna

    Nicolas Chornet held four Senior Vice President roles at Moderna: Manufacturing and Site Head MITC in Harwell, England (2024–2025), International Resilience Manufacturing (2023–2024), International Manufacturing (2020–2023) and Manufacturing and Site Head Norwood (2019–2020). Former General Director (Site Head) of Novartis Technical Operations Solids Site Spain (2015–2019). Suited to questions on international manufacturing and leading a site outside the US.

    Is this you? Claim your profile and get paid for calls.

  9. Sean Gaskell

    LinkedIn

    Experience: SVP, Global Drug Substance Operations · Moderna

    Sean Gaskell, SVP, Global Drug Substance Operations at Moderna since May 2023, was SVP, Chief Technical Officer at Alvotech (2020–2023) and VP, Manufacturing Operations & Site Head at Novartis (2018–2020). The summary centers on transforming manufacturing organizations from early-stage clinical development to commercial supply across small molecules, biologics, gene therapies and mRNA vaccines, which is the exact scaling question.

    Is this you? Claim your profile and get paid for calls.

  10. Tara Tibbs Jones, PhD

    LinkedIn

    Experience: SVP Drug Product Operations and Global Head of MS&T AS&T · Moderna

    SVP Drug Product Operations and Global Head of MS&T AS&T at Moderna since July 2025, after SVP Global Drug Product Operations (2023–2025) and Senior Vice President North America Operations (2022–2023) there. Tara Tibbs Jones, PhD was Vice President Drug Substance Operations (2021–2022) and Executive Director, Drug Substance Plant Manager (2019–2021) at Amgen. A good call for questions linking manufacturing science and technology with drug product operations.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For running or opening a plant, choose among the five site heads: Amanda Ashcraft and Jeff Savard for Norwood drug substance, Elizabeth Sullivan and Deborah Soto-Ortega for INT, and Nicolas Chornet for the UK MITC site. Network-wide questions on drug substance or drug product suit Sean Gaskell, Tara Tibbs Jones, PhD or Michelle Rodriguez, and Jake Haworth has held research and early development operations titles.

Questions to take into the conversation

  1. 01What does it take to start up a new mRNA manufacturing site, from construction through its first clinical batches?
  2. 02How should drug substance and drug product operations hand off work, and where do the two networks share technical teams?
  3. 03What changes in site operations and quality systems when a product moves from clinical to commercial supply?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Biotechnology